Reserved for SRC inhibitor saracatinib impairs oxaliplatin uptake in colorectal cancer

50% off the $29.99 Custom Kit. Use at checkout:

SARACATINIBI50

⚡ This is your brand? Claim your page FREE and bring it to life on AI search.

SRC inhibitor saracatinib impairs oxaliplatin uptake in colorectal cancer

Name: SRC inhibitor saracatinib impairs oxaliplatin uptake in colorectal cancer - AI Visibility Score
Creator: Engagemii
Published: 2026-07-12T01:33:01.112Z
License: https://creativecommons.org/licenses/by/4.0/

Unclaimed

AEO Score: 3/10

Monitoring for AI engine activity

In the Engagemii AEO index

#3,006,109 of 3,459,020 in Technology for AI visibility

saracatinib.info

What this score means

Your AEO score measures whether AI search engines (ChatGPT, Claude, Perplexity, Gemini) can actually read your site and cite it in answers. Two-thirds of websites are invisible to them. SRC inhibitor saracatinib impairs oxaliplatin uptake in colorectal cancer just got measured.

3/10 means SRC inhibitor saracatinib impairs oxaliplatin uptake in colorectal cancer is currently invisible to AI search. Most AI assistants will not cite your brand when asked about your category. Claiming and applying the fixes below is the fastest way to change that.

About SRC inhibitor saracatinib impairs oxaliplatin uptake in colorectal cancer

SRC inhibitor saracatinib impairs oxaliplatin uptake in colorectal cancer is a brand in the technology category. View their AI visibility score and details below.

Key Topics

SRC inhibitor saracatinib impairs oxaliplatin uptake in colorectal cancer

The National Study centers of Wellbeing of the United States believed that more than 80% on the bacterial infections in the human population will be biofilm related and that affected person mortality connected with biofilms is definitely substantial (12)

From this qualitative analysis, we can conclude that the rDNA copy number is not reduced in the mutants

Likeness measure of miRs in the several groups was done employing Half Sq Euclidean Length method and ordering function of miRs was performed on the basis of Type rank

MYB is aberrantly expressed in malignant cases of pancreas and established PC cell lines, whereas remaining undetectable in normal pancreas

We all performed a Gene Ontology (GO) richness analysis regarding biological improvement (BP)

Details

Industry: Technology

saracatinib.info

AI Visibility Breakdown

Structured Data

Content Structure

Entity Clarity

E-E-A-T Signals

Technical AEO

AI Discoverability

Is this your brand?

Claim free. You'll see:

✓

Your full 6-category score breakdown

✓

Exact fixes: robots.txt, schema, llms.txt

✓

AI bot crawls from ChatGPT, Claude, Perplexity, Gemini

✓

Personal 50% off code at checkout

Password (8+ characters)

Already have an account? Sign in

Picked for SRC inhibitor saracatinib impairs oxaliplatin uptake in colorectal cancer: Tech & Electronics

Tech Shoppers Do More Research Than Anyone. Are You There When They're Looking?

Tech buyers are the most research-intensive shoppers on the internet.

Continue reading in your free Engagemii portal

Free signup unlocks the full article plus your personalized AEO fix list for SRC inhibitor saracatinib impairs oxaliplatin uptake in colorectal cancer.

Source & Attribution

Scored by Engagemii on July 12, 2026. Methodology: engagemii.com/aeo/methodology

Source URL: https://engagemii.com/aeo/brands/saracatinib-info

Cite this score: Engagemii (2026). "AEO Score for SRC inhibitor saracatinib impairs oxaliplatin uptake in colorectal cancer." Retrieved from https://engagemii.com/aeo/brands/saracatinib-info

Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.